VCYT – Veracyte, Inc.
Float Short %
6.45
Margin Of Safety %
-11
Put/Call OI Ratio
0.22
EPS Next Q Diff
-0.18
EPS Last/This Y
1.33
EPS This/Next Y
-0.05
Price
42.27
Target Price
49.18
Analyst Recom
1.62
Performance Q
21.64
Relative Volume
1.4
Beta
1.91
Ticker: VCYT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | VCYT | 42.51 | 0.14 | 0.38 | 1962 |
| 2025-12-29 | VCYT | 42.91 | 0.14 | 1.00 | 1991 |
| 2025-12-30 | VCYT | 42.27 | 0.14 | 0.00 | 1992 |
| 2025-12-31 | VCYT | 42.12 | 0.14 | 0.00 | 1983 |
| 2026-01-02 | VCYT | 42.37 | 0.14 | 0.40 | 1986 |
| 2026-01-05 | VCYT | 43.61 | 0.14 | 7.50 | 1996 |
| 2026-01-06 | VCYT | 45.61 | 0.15 | 0.19 | 2010 |
| 2026-01-07 | VCYT | 45.07 | 0.15 | 0.00 | 2074 |
| 2026-01-08 | VCYT | 43.55 | 0.15 | 0.00 | 2074 |
| 2026-01-09 | VCYT | 41.98 | 0.15 | 0.00 | 2082 |
| 2026-01-12 | VCYT | 43.39 | 0.15 | 0.00 | 2084 |
| 2026-01-13 | VCYT | 43.03 | 0.14 | 0.71 | 2200 |
| 2026-01-14 | VCYT | 42.25 | 0.14 | 8.62 | 2212 |
| 2026-01-15 | VCYT | 40.8 | 0.23 | 9.42 | 2389 |
| 2026-01-16 | VCYT | 41.58 | 0.19 | 77.25 | 2244 |
| 2026-01-20 | VCYT | 41.7 | 0.25 | 7.00 | 2253 |
| 2026-01-21 | VCYT | 43.3 | 0.22 | 0.00 | 2215 |
| 2026-01-22 | VCYT | 43.82 | 0.22 | 0.87 | 2230 |
| 2026-01-23 | VCYT | 42.28 | 0.22 | 0.07 | 2249 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | VCYT | 42.51 | 8.7 | 69.4 | 1.65 |
| 2025-12-29 | VCYT | 42.91 | 8.7 | 71.2 | 1.65 |
| 2025-12-30 | VCYT | 42.26 | 8.7 | 68.5 | 1.65 |
| 2025-12-31 | VCYT | 42.12 | 8.7 | 69.7 | 1.65 |
| 2026-01-02 | VCYT | 42.37 | 8.7 | 70.8 | 1.65 |
| 2026-01-05 | VCYT | 43.61 | 8.7 | 73.3 | 1.65 |
| 2026-01-06 | VCYT | 45.68 | 8.2 | 75.4 | 1.65 |
| 2026-01-07 | VCYT | 45.10 | 8.2 | 68.8 | 1.65 |
| 2026-01-08 | VCYT | 43.51 | 8.2 | 66.2 | 1.65 |
| 2026-01-09 | VCYT | 42.04 | 8.2 | 66.2 | 1.65 |
| 2026-01-12 | VCYT | 43.46 | 8.2 | 73.9 | 1.65 |
| 2026-01-13 | VCYT | 43.06 | 8.2 | 69.1 | 1.65 |
| 2026-01-14 | VCYT | 42.42 | 7.9 | 68.5 | 1.65 |
| 2026-01-15 | VCYT | 40.98 | 7.9 | 66.3 | 1.65 |
| 2026-01-16 | VCYT | 41.57 | 7.9 | 71.7 | 1.65 |
| 2026-01-20 | VCYT | 41.70 | 8.7 | 70.5 | 1.65 |
| 2026-01-21 | VCYT | 43.32 | 8.7 | 74.5 | 1.65 |
| 2026-01-22 | VCYT | 43.83 | 8.7 | 71.5 | 1.65 |
| 2026-01-23 | VCYT | 42.27 | 8.7 | 66.2 | 1.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | VCYT | -10.01 | 6.18 | 6.80 |
| 2025-12-29 | VCYT | -10.01 | 6.11 | 6.80 |
| 2025-12-30 | VCYT | -10.01 | 6.11 | 6.80 |
| 2025-12-31 | VCYT | -10.01 | 6.11 | 6.80 |
| 2026-01-02 | VCYT | -10.01 | 6.11 | 6.80 |
| 2026-01-05 | VCYT | -10.01 | 6.12 | 6.80 |
| 2026-01-06 | VCYT | -10.01 | 6.12 | 6.80 |
| 2026-01-07 | VCYT | -10.01 | 6.12 | 6.80 |
| 2026-01-08 | VCYT | -10.01 | 6.12 | 6.80 |
| 2026-01-09 | VCYT | -10.01 | 6.12 | 6.80 |
| 2026-01-12 | VCYT | -9.70 | 4.29 | 6.80 |
| 2026-01-13 | VCYT | -10.01 | 4.29 | 6.45 |
| 2026-01-14 | VCYT | -10.01 | 4.29 | 6.45 |
| 2026-01-15 | VCYT | -10.01 | 4.29 | 6.45 |
| 2026-01-16 | VCYT | -10.01 | 4.29 | 6.45 |
| 2026-01-20 | VCYT | -10.01 | 4.67 | 6.45 |
| 2026-01-21 | VCYT | -10.01 | 4.67 | 6.45 |
| 2026-01-22 | VCYT | -10.01 | 4.67 | 6.45 |
| 2026-01-23 | VCYT | -10.01 | 4.67 | 6.45 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.51
Avg. EPS Est. Current Quarter
0.39
Avg. EPS Est. Next Quarter
0.33
Insider Transactions
-10.01
Institutional Transactions
4.67
Beta
1.91
Average Sales Estimate Current Quarter
131
Average Sales Estimate Next Quarter
130
Fair Value
37.82
Quality Score
86
Growth Score
69
Sentiment Score
94
Actual DrawDown %
50.9
Max Drawdown 5-Year %
-81.2
Target Price
49.18
P/E
111.32
Forward P/E
26.13
PEG
0.33
P/S
6.75
P/B
2.66
P/Free Cash Flow
34.02
EPS
0.38
Average EPS Est. Cur. Y
1.65
EPS Next Y. (Est.)
1.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
6.12
Relative Volume
1.4
Return on Equity vs Sector %
-24.9
Return on Equity vs Industry %
-8.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.22
EBIT Estimation
66.2
Veracyte, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 824
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
stock quote shares VCYT – Veracyte, Inc. Stock Price stock today
news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte, Inc. yahoo finance google finance
stock history VCYT – Veracyte, Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading